ask="1.89"
ask_size="1500"
average_daily_volume="228287"
bid="1.46"
bid_size="3000"
book_value="0.34"
change="-0.05"
change_from_200_day_moving_average="-0.33"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-3.58"
change_From_52_week_low="0.41"
change_in_percent="-3.18%"
close="1.52"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.59"
high_52_weeks="5.10"
last_trade_date="1/12/2017"
last_trade_price="1.52"
last_trade_size="200"
last_trade_time="3:58pm"
low="1.52"
low_52_weeks="1.11"
market_capitalization="14.57M"
moving_average_200_day="1.85"
moving_average_50_day="1.70"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.56"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-17.99%"
percent_change_from_50_day_moving_average="-10.37%"
percent_change_from_52_week_high="-70.20%"
percent_change_from_52_week_low="+36.94%"
previous_close="1.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.63"
price_per_sales="29.57"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="EYEG"
volume="51455"
weeks_range_52="1.11 - 5.10"
